Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory From the American Heart Association

Key Points

• To project the future financial and health burden of cardiovascular risk factors and overt cardiovascular disease in the United States through 2050.
• Economic advisory panel evaluated national epidemiological trends and cost projections for cardiovascular disease and stroke through 2050.
• Assessed population-level strategies and cost-effective policy frameworks aimed at mitigating projected expenditures and advancing health equity.
• The total economic burden driven by cardiovascular risk factors and overt cardiovascular disease is projected to rise substantially over the coming decades.
• Strategic deployment of cost-effective cardiovascular health interventions and public health policies is critical to contain escalating medical costs and improve health equity.